Arrhythmia: Clinical Trials

21 trials for Arrhythmia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed. 21 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Completed 21
Phase 21Completed 1

Follow Arrhythmia: new trials by email Literature Review of Arrhythmia trials Research Report on Arrhythmia

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Colchicine on the Incidence of Atrial Fibrillation in Open Heart Surgery Patients
Colchicine - Arrhythmia
Phase 3CompletedJordan Collaborating Cardiology Group3602012-10-012018-01-23
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
THERMOCOOL® SMARTTOUCH™ Catheter - Heart Diseases, Arrhythmia
Phase 3CompletedBiosense Webster, Inc.1722011-06-012025-02-04
Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients
Docosahexaenoic acid (DHA), Placebo - Arrhythmia
Phase 2 / Phase 3CompletedCampus Bio-Medico University502008-06-012009-11-25
Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
Olmesartan - Heart Disease, Arrhythmia
Phase 3CompletedAtrial Fibrillation Network4222005-01-012012-09-11
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter, Antiarrhythmic drug - Heart Diseases, Arrhythmia
Phase 3CompletedBiosense Webster, Inc.1672004-10-012017-10-24
SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia
Supplementation with fish oil versus placebo - Arrhythmia
Phase 3CompletedWageningen Centre for Food Sciences5462001-10-012006-07-21
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
Azimilide Dihydrochloride, placebo - Arrhythmia
Phase 3CompletedForest Laboratories6332001-09-012011-10-03
Public Access Defibrillation (PAD) Community Trial
defibrillator - Arrhythmia, Heart Arrest
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1999-09-012016-04-14
Fatty Acid Antiarrhythmia Trial (FAAT)
dietary polyunsaturated fatty acid - Arrhythmia, Heart Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1999-03-012016-03-16
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
amiodarone, defibrillators, implantable - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1997-05-012016-05-13
Mode Selection Trial in Sinus Node Dysfunction (MOST)
pacemaker, artificial - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedMt. Sinai Medical Center, Miami1995-06-012016-02-23
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
amiodarone, sotalol, propafenone - Arrhythmia, Atrial Fibrillation
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1995-03-012016-03-25
Coronary Artery Bypass Graft (CABG) Patch Trial
defibrillators, implantable - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1992-12-012016-11-07
Antiarrhythmics Versus Implantable Defibrillators (AVID)
defibrillators, implantable, amiodarone amiodarone, sotalol - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1992-09-012016-04-14
Multicenter Unsustained Tachycardia Trial (MUSTT)
electrophysiology, anti-arrhythmia agents, defibrillators, implantable - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1991-09-012017-01-16
Digitalis Investigation Group (DIG)
digitalis - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1990-06-012016-07-12
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
amiodarone, imipramine, mexiletine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Washington1987-04-012013-07-29
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
warfarin - Arrhythmia, Atrial Fibrillation
Phase 3CompletedMassachusetts General Hospital1985-07-012014-04-10
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
electrophysiology, electrocardiography, ambulatory, imipramine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Utah1985-07-012016-01-21
Evaluation of SC-V Versus Conventional CPR
cardiopulmonary resuscitation - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1981-09-012013-11-26

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Arrhythmias, Cardiac (21)  ·  Heart Diseases (17)  ·  Cardiovascular Diseases (12)  ·  Death, Sudden, Cardiac (8)  ·  Ventricular Fibrillation (7)  ·  Atrial Fibrillation (6)  ·  Myocardial Infarction (5)  ·  Tachycardia, Ventricular (4)  ·  Coronary Disease (3)  ·  Heart Arrest (3)  ·  Myocardial Ischemia (3)  ·  Heart Failure (2)  ·  Stroke (2)  ·  Arrhythmia, Sinus (1)  ·  Cerebrovascular Disorders (1)

Broader conditions

Pathologic Processes (21)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Cardiovascular Diseases (9)  ·  Death (8)  ·  Death, Sudden (8)  ·  Heart Arrest (7)  ·  Vascular Diseases (7)  ·  Cardiac Conduction System Disease (5)  ·  Infarction (5)  ·  Ischemia (5)  ·  Necrosis (5)  ·  Heart Diseases (4)  ·  Tachycardia (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)

Interventions

Amiodarone (4)  ·  Defibrillators, Implantable (4)  ·  Sotalol (4)  ·  Procainamide (3)  ·  Quinidine (3)  ·  Anti-Arrhythmia Agents (2)  ·  Imipramine (2)  ·  Mexiletine (2)  ·  Pacemaker, Artificial (2)  ·  Propafenone (2)  ·  Adrenergic beta-Antagonists (1)  ·  Ambulatory Care Facilities (1)  ·  Cardiopulmonary Resuscitation (1)  ·  Catheter Ablation (1)  ·  Colchicine (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (10)  ·  Biosense Webster, Inc. (2)  ·  Atrial Fibrillation Network (1)  ·  Campus Bio-Medico University (1)  ·  Forest Laboratories (1)  ·  Jordan Collaborating Cardiology Group (1)  ·  Massachusetts General Hospital (1)  ·  Mt. Sinai Medical Center, Miami (1)  ·  University of Utah (1)  ·  University of Washington (1)  ·  Wageningen Centre for Food Sciences (1)

Countries

Italy (3)  ·  Belgium (2)  ·  Canada (2)  ·  Czechia (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Poland (2)  ·  United States (2)  ·  Austria (1)  ·  Brazil (1)  ·  France (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Kerry Lee (3)  ·  H. Greene (2)  ·  Alfred Hallstrom (1)  ·  Allan Barker (1)  ·  Andrea Natale, MD (1)  ·  Andreas Goette, MD (1)  ·  Charles Laubach (1)  ·  David J Wilber, MD (1)  ·  David Richardson (1)  ·  David Wilber, MD (1)  ·  Douglas L Packer, MD (1)  ·  E. Michau (1)  ·  Edgar Lichstein (1)  ·  Evert G Schouten, MD, PhD (1)

Results publications

PMID 16772624, PMID 18371559, PMID 19704100, PMID 19917887, PMID 20103757, PMID 20884379, PMID 20940250, PMID 22032709, PMID 22157519, PMID 23280225, PMID 23541974, PMID 24016511, PMID 24351885, PMID 24727258, PMID 25125294, PMID 27502857, PMID 27514751, PMID 28974568, PMID 29759747, PMID 31412732

NIH funding

R01HL031472 (1), R01HL033233 (1), R01HL034071 (1), R01HL062154 (1), U01HL045700 (1), U01HL048120 (1), U01HL048159 (1), U01HL049804 (1), U01HL055766 (1)